• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[低级别和低分期膀胱癌的治疗]

[Treatment of low grade and low stage urinary bladder cancer].

作者信息

Miura T, Sakuramoto T, Noguchi S, Shuin T, Moriyama M, Kubota Y

出版信息

Hinyokika Kiyo. 1985 Feb;31(2):265-71.

PMID:4013945
Abstract

Fifty-seven patients with low-grade and low-stage urinary bladder cancer were treated at our University Hospital between 1970 and 1980. The incidence of low grade and low stage cases was higher in the young group than in the older group, and in male than in female (p less than 0.05). Most of the patients were well-controlled by either TUR or other conservative therapies. The 5-year relative survival rate was 113%. The 5-year actual cumulative recurrence rate after TUR was 63%, whereas, the 5-year actual cumulative recurrence rate was only 35.4% in those who received intravesical instillation therapy and 25% in those who undergone RCH (Radio-Chemo-Hyperthermia) therapy. Five patients (9%) showed an increase of tumor grade from low to intermediate at the time of intravesical recurrence, but no patient showed a change from low to high grade.

摘要

1970年至1980年间,我校医院共治疗了57例低级别、低分期的膀胱癌患者。低级别、低分期病例在年轻组中的发病率高于老年组,男性高于女性(p<0.05)。大多数患者通过经尿道切除术(TUR)或其他保守治疗得到了良好控制。5年相对生存率为113%。TUR术后5年实际累积复发率为63%,而接受膀胱内灌注治疗的患者5年实际累积复发率仅为35.4%,接受放射化学热疗(RCH)的患者为25%。5例患者(9%)在膀胱内复发时肿瘤分级从低级别升至中级别,但没有患者从低级别变为高级别。

相似文献

1
[Treatment of low grade and low stage urinary bladder cancer].[低级别和低分期膀胱癌的治疗]
Hinyokika Kiyo. 1985 Feb;31(2):265-71.
2
[Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].[卡介苗辅助膀胱内灌注治疗3级浅表性膀胱癌的结果]
Hinyokika Kiyo. 2004 Nov;50(11):767-71.
3
Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.局部膀胱热疗联合膀胱内化疗治疗高级别浅表性膀胱癌。
Urology. 2004 Mar;63(3):466-71. doi: 10.1016/j.urology.2003.10.036.
4
Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.经尿道切除浅表性膀胱癌后卡介苗的免疫预防性膀胱内应用。
Croat Med J. 2003 Apr;44(2):187-92.
5
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.根据日本登记膀胱癌患者的数据得出的Ta、T1期非肌层浸润性膀胱癌肿瘤复发的临床结果:日本泌尿外科学会1999 - 2001年报告
Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.
6
The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.p53和bcl-2在浅表性膀胱移行细胞癌中的表达及其在术后膀胱内化疗结局中的作用。
Anticancer Res. 1998 Nov-Dec;18(6B):4717-21.
7
The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.膀胱T1期肿瘤患者接受膀胱内丝裂霉素治疗后重复经尿道切除术对复发率和进展率的影响:一项前瞻性随机临床试验。
J Urol. 2006 May;175(5):1641-4. doi: 10.1016/S0022-5347(05)01002-5.
8
Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.膀胱内卡介苗治疗T1期3级膀胱移行细胞癌:57例患者的复发、进展及生存情况研究
J Urol. 2003 Jun;169(6):2110-2. doi: 10.1097/01.ju.0000066840.42991.4a.
9
Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.高危浅表性膀胱肿瘤患者膀胱内卡介苗治疗失败后的膀胱切除术:术前前列腺受累作为一个预后因素。
Eur Urol. 2005 Jul;48(1):53-9; discussion 59. doi: 10.1016/j.eururo.2005.03.021. Epub 2005 Apr 7.
10
Single instillation of mitomycin C reduces 1st year recurrence following transurethral resection of non-muscle invasive bladder cancer.单次灌注丝裂霉素C可降低非肌层浸润性膀胱癌经尿道切除术后第一年的复发率。
J Ayub Med Coll Abbottabad. 2007 Oct-Dec;19(4):18-20.